Company / Current Liabilities
AMICUS THERAPEUTICS, INC. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$237.8M
FY2025
5-year range
$139.0M / $237.8M
FY2021-FY2025
Trend
+59.9%
vs FY2024
Sector context
#55 of 213
Health Care
What the data says
At $238M, AMICUS THERAPEUTICS, INC.'s current liabilities ranks #159 of 213 in the Health Care sector. Current Liabilities has fluctuated over the past 10 years, ranging from $70M in FY2017 to $238M in FY2025.
Based on SEC 10-K filings.
$238M in FY2025 with a 5-year CAGR of +12.9%.
Increased from $168M to $238M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +19.6%
- 5-Year CAGR
- +12.9%
- 10-Year CAGR
- -
Sector benchmark
#159 of 213 in Health CareTop 74% of 213This company $237.8M Sector average $1.6B
▼
-85.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.9%, indicating consistent growth.
- In FY2025, current liabilities increased 59.9% year-over-year.
- Ranks #55 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $237.8M | +59.9% |
| FY2024 | $148.7M | -11.3% |
| FY2023 | $167.7M | +20.6% |
| FY2022 | $139.0M | -4.8% |
| FY2021 | $146.0M | +12.6% |
| FY2020 | $129.7M | +0.7% |
| FY2019 | $128.8M | +49.6% |
| FY2018 | $86.1M | +23.0% |
| FY2017 | $70.0M | -36.9% |
| FY2016 | $111.0M | +50.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026